Sylvain Costes

Dr. Sylvain Costes

NASA Ames Research Center
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2004 in Biophysical Journal
Verified
Journal Article
Closed access
Sylvain CostesSylvain Costes
Sylvain Costes
DDDirk Daelemans
Dirk Daelemans
ECEdward H. Cho
Edward H. Cho
ZDZachary Dobbin
Zachary Dobbin
GPGeorge Pavlakis
George Pavlakis
SLStephen Lockett
Stephen Lockett

1 March 2011 in Cell
Verified
Journal Article
Closed access
ICIrene Chiolo
Irene Chiolo
AMA. Minoda
A. Minoda
SCSerafin U. Colmenares
Serafin U. Colmenares
APAris Polyzos
Aris Polyzos
Sylvain CostesSylvain Costes
Sylvain Costes
GKGary H. Karpen
Gary H. Karpen

1 November 2020 in Cell
Verified
Journal Article
Closed access
EAEbrahim Afshinnekoo
Ebrahim Afshinnekoo
RSRyan T. Scott
Ryan T. Scott
MMMatthew J. MacKay
Matthew J. MacKay
EPEloise Pariset
Eloise Pariset
ECEgle Cekanaviciute
Egle Cekanaviciute
ABAfshin Beheshti
Afshin Beheshti

1 January 2003 in Molecular and Cellular Biology
Verified
Journal Article
Open access
PDF file
HYHsin-Sheng Yang
Hsin-Sheng Yang
AJAaron P. Jansen
Aaron P. Jansen
AKAnton Komar
Anton Komar
XZXiaojing Zheng
Xiaojing Zheng
WMWilliam C. Merrick
William C. Merrick
NCNancy H. Colburn
Nancy H. Colburn
Pdcd4 is a novel transformation suppressor that inhibits tumor promoter-induced neoplastic transformation and the activation of AP-1-dependent transcription required for transformation. A yeast two-hybrid analysis revealed that Pdcd4 associates with the eukaryotic translation initiation factors eIF4AI and eIF4AII. Immunofluorescent confocal microscopy showed that Pdcd4 colocalizes with eIF4A in the cytoplasm. eIF4A is an ATP-dependent RNA helicase needed to unwind 5′ mRNA secondary structure. Recombinant Pdcd4 specifically inhibited the helicase activity of eIF4A and eIF4F. In vivo translation assays showed that Pdcd4 inhibited cap-dependent but not internal ribosome entry site (IRES)-dependent translation. In contrast, Pdcd4D418A, a mutant inactivated for binding to eIF4A, failed to inhibit cap-dependent or IRES-dependent translation or AP-1 transactivation. Recombinant Pdcd4 prevented eIF4A from binding to the C-terminal region of eIF4G (amino acids 1040 to 1560) but not to the middle region of eIF4G(amino acids 635 to 1039). In addition, both Pdcd4 and Pdcd4D418A bound to the middle region of eIF4G. The mechanism by which Pdcd4 inhibits translation thus appears to involve inhibition of eIF4A helicase, interference with eIF4A association-dissociation from eIF4G, and inhibition of eIF4A binding to the C-terminal domain of eIF4G. Pdcd4 binding to eIF4A is linked to its transformation-suppressing activity, as Pdcd4-eIF4A binding and consequent inhibition of translation are required for Pdcd4 transrepression of AP-1.

1 August 2008 in Cancer Research
Verified
Journal Article
Closed access
PDF file
DBDalit Barkan
Dalit Barkan
HKHynda Kleinman
Hynda Kleinman
JSJustin L. Simmons
Justin L. Simmons
HAHolly Asmussen
Holly Asmussen
AKAnil K. Kamaraju
Anil K. Kamaraju
JGJeffrey E. Green
Jeffrey E. Green
Metastatic breast cancer may emerge from latent tumor cells that remain dormant at disseminated sites for many years. Identifying mechanisms regulating the switch from dormancy to proliferative metastatic growth has been elusive due to the lack of experimental models of tumor cell dormancy. We characterized the in vitro growth characteristics of cells that exhibit either dormant (D2.0R, MCF-7, and K7M2AS1.46) or proliferative (D2A1, MDA-MB-231, and K7M2) metastatic behavior in vivo. Although these cells proliferate readily in two-dimensional culture, we show that when grown in three-dimensional matrix, distinct growth properties of the cells were revealed that correlate to their dormant or proliferative behavior at metastatic sites in vivo. In three-dimensional culture, cells with dormant behavior in vivo remained cell cycle arrested with elevated nuclear expression of p16 and p27. The transition from quiescence to proliferation of D2A1 cells was dependent on fibronectin production and signaling through integrin β1, leading to cytoskeletal reorganization with filamentous actin (F-actin) stress fiber formation. We show that phosphorylation of myosin light chain (MLC) by MLC kinase (MLCK) through integrin β1 is required for actin stress fiber formation and proliferative growth. Inhibition of integrin β1 or MLCK prevents transition from a quiescent to proliferative state in vitro. Inhibition of MLCK significantly reduces metastatic outgrowth in vivo. These studies show that the switch from dormancy to metastatic growth may be regulated, in part, through epigenetic signaling from the microenvironment, leading to changes in the cytoskeletal architecture of dormant cells. Targeting this process may provide therapeutic strategies for inhibition of the dormant-to-proliferative metastatic switch. [Cancer Res 2008;68(15):6241–50]

19 December 2011 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
TNTeresa Neumaier
Teresa Neumaier
JSJoel Swenson
Joel Swenson
CPChristopher Pham
Christopher Pham
APAris Polyzos
Aris Polyzos
ALAlvin T. Lo
Alvin T. Lo
Sylvain CostesSylvain Costes
Sylvain Costes
The concept of DNA “repair centers” and the meaning of radiation-induced foci (RIF) in human cells have remained controversial. RIFs are characterized by the local recruitment of DNA damage sensing proteins such as p53 binding protein (53BP1). Here, we provide strong evidence for the existence of repair centers. We used live imaging and mathematical fitting of RIF kinetics to show that RIF induction rate increases with increasing radiation dose, whereas the rate at which RIFs disappear decreases. We show that multiple DNA double-strand breaks (DSBs) 1 to 2 μm apart can rapidly cluster into repair centers. Correcting mathematically for the dose dependence of induction/resolution rates, we observe an absolute RIF yield that is surprisingly much smaller at higher doses: 15 RIF/Gy after 2 Gy exposure compared to approximately 64 RIF/Gy after 0.1 Gy. Cumulative RIF counts from time lapse of 53BP1-GFP in human breast cells confirmed these results. The standard model currently in use applies a linear scale, extrapolating cancer risk from high doses to low doses of ionizing radiation. However, our discovery of DSB clustering over such large distances casts considerable doubts on the general assumption that risk to ionizing radiation is proportional to dose, and instead provides a mechanism that could more accurately address risk dose dependency of ionizing radiation.